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Summary
In blood, transcription factor C/EBPa is essential for myeloid differentiation and has been
implicated in regulating self-renewal of fetal liver (FL) hematopoietic stem cells (HSCs).
However, its function in adult HSCs has remained unknown. Here, using an inducible knockout
model we found that C/EBPa deficient adult HSCs underwent a pronounced expansion with
enhanced proliferation, characteristics resembling FL HSCs. Consistently, transcription profiling
of C/EBPa deficient HSCs revealed a gene expression programme similar to FL HSCs. Moreover
we observed that age-specific C/EBPa expression correlated with its inhibitory effect on HSC cell
cycle. Mechanistically we identified N-Myc as C/EBPa downstream target, and loss of C/EBPa
resulted in de-repression of N-Myc. Our data establish C/EBPa as a central determinant in the
switch from fetal to adult HSCs.
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Introduction
Hematopoiesis is maintained by a small group of multipotent hematopoietic stem cells
(HSCs), which can rapidly divide and have an ability to remain quiescence. This ensures
appropriate numbers of HSCs to sustain a sufficient supply of mature blood cells throughout
lifetime. During early development, fetal HSCs undergo rapid self-renewal divisions, which
lead to a massive expansion of the HSC pool to meet the demands of adult hematopoiesis1,2.
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By contrast, adult HSCs divide infrequently with the majority of cells in a quiescent G0
phase, and are maintained at relatively constant cell numbers3-7. New evidence now shows
that the proliferation of HSCs continues until three weeks post-birth, afterwards HSCs
undergo an abrupt change in their cycling activity and become quiescent at the end of the 4th
week8. This process is also accompanied by alternations in differentiated cell output and
self-renewal capacity of HSCs1,9,10. Interestingly, these dramatic and coordinated changes
in biological properties correlate with changes in HSC gene expression10,11. It is clear that
fetal and adult HSCs are sustained by different transcriptional programs. For instance,
transcription factor Sox17 is required for the maintenance of fetal and neonatal, but not adult
HSCs11. By contrast, Bmi-112, Gfi-113 and Etv614 are needed for self-renewal of adult, but
not fetal HSCs. However, the precise molecular circuitry that actually determines the
transition of HSC properties during development remains unknown.
C/EBPa is a member of the basic leucine zipper transcription factor family, which regulates
cell-cycle exit and differentiation in various tissues15-17. In hematopoietic system, previous
studies have established a critical, non-redundant role of C/EBPa in granulopoiesis.
Disruption of C/EBPa blocks the transition from the common myeloid progenitors to the
granulocyte/monocyte progenitor, thereby leading to the loss of mature granulocytes18,19. In
addition, we have previously reported that C/EBPa negatively regulates fetal HSCs self-
renewal, as C/EBPa null FL HSCs exhibit enhanced repopulation activity in competitive
transplantation assays, whereas their total number and cell cycle kinetics are not affected19.
C/EBPa also appears to be crucial in leukemogenesis, as C/EBPa silencing or mutations
leading to reduced activity are frequently found in human acute myeloid leukemia
patients20,21. However, despite the significance of C/EBPa in fetal hematopoiesis and
human leukemia, the physiological role of C/EBPa in adult hematopoiesis, especially in
adult HSC biology, has remained unclear.
In this report, using a C/EBPa conditional knockout mouse model that circumvents the
perinatal mortality of the conventional knockout mice, we demonstrate that loss of C/EBPa
in adult HSCs confers fetal HSC characteristics, including enhanced proliferation, increased
number of functional long term HSCs (LT-HSCs), advanced repopulating ability as well as
altered transcriptional profile that resembles fetal HSCs. Furthermore, we identified N-Myc
as a downstream target of C/EBPa and showed that transcriptional repression of N-Myc by
C/EBPa is at least partially required for acquiring and maintaining adult quiescence of
HSCs.
Results
Phenotypic LT-HSCs increase in adult C/EBPa deficient mice
To address whether C/EBPa is involved in adult HSC function, we bred C/EBPaloxP/loxP
mice with transgenic Mx1-Cre mice to allow IFN-inducible C/EBPa excision in adult
hematopoietic cells. Administration of three doses of poly(inosinic acid) poly(cytidylic acid)
[pIpC] in Mx1-Cre+C/EBPaloxP/loxP mice induced the excision of C/EBPa in almost all c-
Kit+Sca-1+Lineage- hematopoietic stem and multipotent progenitor cells (HSPCs, also
termed as KSLs) four days after the last injection (hereafter referred to as KO, Figure S1a
and S1b).
Phenotypic examination of HSCs by flow cytometry showed a ~70-fold increase in the
frequency of KSLs in KO bone marrow 5-7 days after pIpC treatment (Figure 1a and 1b).
Despite the significant reduction in bone marrow cellularity (Figure 1c), the total number of
KSLs increased nearly 12-fold in the bone marrow of KO mice (Figure 1d). KSLs were
further analyzed using the combination of CD150 and CD48 (SLAM code) for HSC
identification. CD150+CD48-KSLs (hereafter referred to as SLAM+) are enriched for LT-
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HSCs, while CD48+KSLs contain short-term repopulating HSCs (ST-HSCs) and
multipotent progenitors (MPPs)22,23. C/EBPa excision resulted in a decreased percentage of
SLAM+ cells within the KSL compartment of KO mice (Figure 1a and 1b); however, the
total number of SLAM+KSLs was increased by ~2-fold (Figure 1e). Taken together, loss of
C/EBPa led to an expansion of phenotypic LT-HSCs, despite of a disproportional expansion
of ST-HSC/MPPs (Figure S1c).
Functional LT-HSCs are increased in C/EBPa deficient mice
We next asked whether the increased number of phenotypic SLAM+ LT-HSCs in KO mice
correlated with an increase in functional LT-HSCs. Limiting dilution transplantation assays
were performed to measure the frequency of competitive repopulation units (CRU)24, which
is a reflection of the number of functional HSCs. Analysis of recipients received either
control or KO SLAM+KSLs revealed a ~2-fold increase in the frequency of multipotent
repopulating cells in KO (Figure 1f) and a 4-5 fold increase in the number of functional LT-
HSCs per mouse, when normalized to the total number of SLAM+KLSs (Figure 1e). The
increased frequency and total number of functional LT-HSCs in KO mice were further
confirmed by transplantation of unsorted whole bone marrow cells. Analysis of recipient
animals revealed a 14-fold increase in the frequency of multipotent repopulating cells in KO
mice and consequently a ~5-fold increase in the number of CRU per mouse (Figure 1g). The
presence of B and T cells, but the lack of donor-derived myeloid cells in bone marrow and
peripheral blood, confirmed the reconstitution by KO cells (data not shown). Collectively,
these results suggest that loss of C/EBPa leads to a significant expansion of functional LT-
HSCs, which are highly enriched in the SLAM+ KSL compartment.
Expansion of HSPC pool is cell intrinsic
To examine whether the expansion of KO HSPCs was hematopoietic cell intrinsic effect, we
transplanted bone marrow cells from untreated Mx1-Cre+ C/EBPaloxP/loxP mice into lethally
irradiated Mx1-Cre- C/EBPaloxP/loxP mice. In addition, we performed the reciprocal
transplants of Mx1-Cre- C/EBPaloxP/loxP bone marrow into Mx1-Cre+ C/EBPaloxP/loxP
recipients. C/EBPa excision was induced four months after bone marrow reconstitution
(Figure 2a). A significant expansion of KSLs was recapitulated in the recipients with C/
EBPa excision exclusively in the hematopoietic compartment, but not in those with C/EBPa
excision in the bone marrow environment (Figure 2b, 2c and S2a). Therefore, KSL
expansion in KO mice is a hematopoietic cell intrinsic event.
We also observed that C/EBPa excision led to severe bone marrow cytopenia due to a
myeloid differentiation block19. This raises the possibility that the expansion of KO HSPCs
is a consequence of either the significant loss of hematopoietic cells or the lack of a myeloid
population, an important component of the “hematopoietic environment”. To examine this,
lethally irradiated CD45.1+ congenic recipients were reconstituted with undeleted CD45.2+
Mx1-Cre+C/EBPaloxP/loxP or Mx1-Cre- C/EBPaloxP/loxP bone marrow cells mixed with
CD45.1+ congenic bone marrow cells at 1:4 ratio. Two months after transplantation, mice
were treated with pIpC (Figure 2d). Assessment of the bone marrow one week later revealed
less than 10% reduction of bone marrow cellularity and a ~15% decrease in Mac1+Gr1+
myeloid cells in the KO chimera mice (data not shown). Despite these minor changes in cell
number, we found that the frequency of donor-derived KSLs in Lin- population consistently
displayed a more than 5-fold increase in the KO chimeras, compared to control chimeras
(Figure 2e and Figure S2b). Moreover, CD45.1+ wild type congenic competitors in KO
chimeras showed little difference in KSL frequency compared to congenic competitors in
the control chimera (Figure 2e and S2b). These results demonstrate that the expansion of
KSLs observed in KO mice is not the consequence of cell loss or the lack of mature myeloid
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cells. Collectively, the expansion of KSLs is an intrinsic and HSC specific effect of C/EBPa
deletion.
Loss of quiescence of adult HSCs upon C/EBPa excision
C/EBPa has previously been reported as a cell cycle inhibitor15, we therefore tested if loss of
C/EBPa increased the number of SLAM+ LT-HSCs via enhancing cell cycle activity.
SLAM+KSL cells were stained with a combination of the DNA and RNA dyes Hoechst
33342 and Pyronin Y to distinguish cells in G0, G1, and S-G2/M cell cycle phases.
Interestingly, we observed a 2~3-fold increase of cells in G1 and G2-S/M phases 5 days
after pIpC treatment (Figure 3a and b). The 5 days interval was chosen to avoid secondary
effects of pIpC induced INFa on HSC proliferation, as the transient effect of INFa on HSC
proliferation diminishes 4 days after injections25.
C/EBPa KO mice started to die 10 days following pIpC treatment due to sepsis as a result of
granulocytopenia19. To determine the long-term impact of C/EBPa deficiency on HSC
proliferation, we created bone marrow chimeric mice as described in Figure 2d. C/EBPa
deletion was induced in reconstituted mice 4 month post-transplant and bone marrow cells
were analyzed 4 months later. Assessment of cellular proliferation by BrdU incorporation
assay in these chimeras revealed persistently increased proliferation of HSCs in the absence
of C/EBPa (Figure 3c and d). Of note, the C/EBPa null cell graft was significantly increased
after pIpC injection, as ~80% of SLAM+KSLs were derived from KO in KO chimeras,
compared to ~20% from control in control chimeras (Figure S3a and b). We further
examined the reconstitution ability of KO cells in serial transplantation. The primary
transplants as described above were treated with pIpC and two weeks later 2×106
unfractionated whole bone marrow cells were isolated and transplanted into irradiated
CD45.1+ recipient mice. Four months after transplantation, we observed a dramatic
expansion of KSLs with ~90% of them being KO in mice received the KO chimera bone
marrow. In contrast, mice received the control chimera bone marrow retained stable
chimerism in the KSL compartment (Figure S3c and d). These results indicate an enhanced
competitive repopulation activity of proliferating KO cells.
To further uncover the molecular basis for enhanced HSC proliferation in C/EBPa deficient
mice, we performed Affymetrix-based global gene expression analysis on SLAM+KSLs
sorted from KO and control mice 7 and 21 days (only 4 out of 13 KO mice survived on day
21) after pIpC injections. In line with the functional cell cycle analysis, gene set enrichment
analysis (GSEA) revealed that the expression of proliferation-associated genes was
significantly enriched in KO SLAM+KSLs on both day 7 and day 21 (Figure 3e and Table
S1), whereas the expression of quiescence-associated genes was dramatically depleted in
KOs (Figure 3F and Table S2)26. Quantitative PCR analysis confirmed that C/EBPa KO
SLAM+KSLs exhibited significantly increased expression of mitotic cyclin A2, cyclin B2
and cyclin dependent kinase 4 (cdk4), and decreased expression of cell-cycle inhibitor p21,
as compared to control (Figure 3g).
In contrast to the cell cycle alterations, no obvious difference in apoptosis was detected
between KO and WT cells (Figure S3e), suggesting C/EBPa having a role in maintaining
adult quiescence, but not in survival of HSCs.
Loss of C/EBPa leads to transcriptional alterations that resemble fetal liver (FL) HSCs
Although the observed enhanced proliferation, yet expanded HSC pool and advanced
reconstitution ability of KO HSCs are unusual phenomena for adult HSCs, they are
hallmarks of FL HSCs. This raises a possibility that loss of C/EBPa might restore a fetal
transcriptional program in adult HSCs. We then compared the transcriptomes of adult KO,
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control HSCs, and E15.5 FL HSCs. Unsupervised clustering analysis of differentially
expressed genes (DEG) between KO and control showed that KO adult SLAM+KSLs
coclustered with FL HSCs, with a distinguishable distance to control adult HSCs (Figure
4a). Among 1551 DEGs between KO and control, 1001 genes overlapped with the 1934
DEGs identified by FL and adult control HSC comparison (1.5-fold change-filtered, P <
0.05). Of note, the vast majority of these overlapped genes (950 out of 1001) over-express or
repress accordingly in FL HSCs and KO HSCs, as compared to control HSCs (Figure 4b and
Table S3). Moreover, GSEA revealed that the expression of FL HSC associated genes27 was
significantly enriched in KO adult HSCs, compared to control adult HSCs (Figure 4c and
Table S4). Thus, C/EBPa deletion in adult HSCs leads to the restoration of the gene
expression signature of FL HSCs.
Increased levels of C/EBPa correlate with the acquisition of adult quiescence in HSCs
Transition from actively dividing fetal HSCs to quiescent adult HSCs occurs 3-4 weeks after
birth8. Since C/EBPa KO HSCs failed to maintain properties of adult HSCs and yet acquired
various characteristics of FL HSCs, we then asked whether C/EBPa regulates the
developmental transition of HSC proliferation properties. First, we examined C/EBPa
expression in HSCs using qPCR and observed that levels of C/EBPa increased during
development (Figure 5a). Therefore, C/EBPa expression is inversely correlated with HSC
proliferation 8. Moreover, there was a sharp 2-fold increase in C/EBPa expression in HSCs
from 4-week old mice, compared to HSCs from 2-week old mice. Notably, this is consistent
with the time at which HSCs switch to the non-proliferative state 8. Next, we asked whether
levels of C/EBPa in HSCs correlate with inhibition of HSC proliferation. We excised C/
EBPa in 1.5-week old and 4.5-week old C/EBPa conditional KO mice, respectively.
Assessment of proliferation by BrdU revealed that while there was a nearly 2-fold increase
in the percentage of BrdU+ SLAM+KSLs in 4.5-week KO mice (Figure 5c); no significant
increase was observed in 1.5-week old mice (Figure 5b). qPCR analysis also confirmed
efficient excision of C/EBPa in these cells (data not shown). Last, we asked if over-
expression of C/EBPa in fetal HSCs is sufficient to induce the switch from the proliferative
to the quiescent state. Mac1low KSLs isolated from FLs were transduced with either MSCV-
GFP-C/EBPa (MIG-C/EBPa) or MIG control virus. GFP+c-kit+ cells were isolated 48 hours
later and subjected to cell cycle analysis. Strikingly, FL KSLs over-expressing C/EBPa
demonstrated a more than 7-fold increase of cells in the quiescent G0 phase, compared to
cells infected with control vector, indicating a significantly decreased proliferation (Figure
5d and Figure S4). Together, these data suggest that increased C/EBPa expression
contributes to the acquisition of adult HSC quiescence during ontogeny.
N-Myc is a direct target of C/EBPa and mediates its function in the fetal to adult switch of
HSC proliferative properties
To identify potential C/EBPa downstream pathways involved, enriched pathway analysis
using Ingenuity Systems Pathway Analysis (IPA) was performed on genes that were
differentially expressed upon excision of C/EBPa in HSCs. In line with the increased
proliferation observed, gene sets and pathways that associate with cell cycle, cytoskeleton
organization and HSC self-renewal (such as TGFb and canonical Wnt signaling) were
significantly overrepresented in KO HSCs (Figure 6a and Table S5). N-Myc target gene set
was among the pathways and gene sets that were most significantly altered. N-Myc is a
member of the MYC transcription factor family. Although elimination of either N-Myc or
C-Myc in adult mice showed no effect on HSC proliferation, loss of both genes resulted in
significantly decreased proliferation, suggesting either redundancy and/or a dosage effect of
Myc proteins on HSC proliferation28.
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To investigate whether N-Myc mediates the enhanced proliferation of KO HSCs, we first
confirmed the increase of N-Myc mRNA in KO SLAM+KSLs by qPCR analysis (Figure
6b). To test whether up-regulation of N-Myc in HSCs is specifically caused by the loss of C/
EBPa, we examined N-Myc expression in KO KSLs upon the restoration of C/EBPa
expression and observed more than 90% down-regulation of N-Myc expression (Figure 6c).
Sequence analysis of the N-Myc promoter revealed three putative C/EBPa binding sites
within ~1 kb of the proximal promoter region (Figure 6e). Combined with the rapid down-
regulation of N-Myc, this raised the possibility that C/EBPa modulates N-Myc expression
through direct transcriptional repression. Chromatin immunoprecipitation (ChIP) in Lin-c-
kit+ bone marrow cells clearly showed binding of C/EBPa to endogenous N-Myc promoter
(Figure 6d). To further investigate how C/EBPa suppresses N-Myc transcription, we
performed luciferase reporter assays with either the wild-type N-Myc promoter or its
truncated mutants (Figure 6e). The luciferase activity of the construct containing all three
binding sites was repressed by C/EBPa expression. Deletion of the two distal binding sites
abolished the repression, suggesting that integrity of these consensus sites in the N-Myc
promoter is required for C/EBPa-mediated suppression (Figure 6e). Collectively, we
concluded that C/EBPa directly represses N-Myc transcription by binding to the proximal
region of the N-Myc promoter.
To determine whether increased expression of N-Myc is responsible for the enhanced
proliferation of adult KO HSCs, we knocked down its expression in KO KSLs using
lentivirally expressed shRNAs. Among the three shRNAs tested, N-Myc shRNA 42523 and
42524 showed a marked knocking down and were used in subsequent studies (Figure S5a).
Knocking down N-Myc by shRNA in KO KSLs led to a 4-fold increase in the frequency of
cells in quiescent G0 phase, compared with cells infected with lentivirus carrying control
luciferase shRNAs (Figure 6f and Figure S5b). In contrast, knocking-down N-Myc in
control adult KSLs showed no such effect on their cell cycle, indicating a specific
contribution of N-Myc in C/EBPa regulated HSC proliferation (Figure S5c).
To determine whether the quiescence imposed by increased C/EBPa expression during the
transition from fetal to adult hematopoiesis is also modulated through the inhibition of N-
Myc expression, we first measured the mRNA levels of N-Myc in sorted SLAM+KSLs from
FL and from bone marrow of either newborn or adult mice. Of note, N-Myc showed an
inverse expression pattern as compared to C/EBPa (Figure 6g). To examine whether the
relatively high levels of N-Myc in FL HSCs mediate their active proliferation, we knocked
down N-Myc expression in FL KSLs using shRNA. Reduced levels of N-Myc in FL KSLs
resulted in a significant increase of cells in G0 phase (Figure 6h). Together, these data
strongly support that C/EBPa regulated fetal to adult switch of HSCs, is at least partially
mediated by direct transcriptional repression of N-Myc by C/EBPa.
Discussion
In this study, we demonstrate that deletion of C/EBPa leads to increased proliferation with
an expansion of HSC pool. Moreover, the transcriptome of adult C/EBPa KO HSCs
resembled that of fetal HSCs. We identified N-Myc as a direct target of C/EBPa and a key
mediator of the C/EBPa induced transition from fetal to adult HSCs. Our data establish that
a finely orchestrated balance of N-Myc and C/EBPa controls the developmental change of
HSC proliferative properties (Figure 7).
One striking feature of HSCs is that actively dividing HSCs become quiescent around 3-4
weeks after birth 8. However, the molecular mechanisms underlying this phenomenon are
still under investigation11,27,29. Our data indicate that the fetal to adult switch of HSC is
controlled by C/EBPa, probably in a dosage sensitive manner. It is possible that different
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levels of C/EBPa control different downstream targets in HSCs through either direct
transcriptional regulation or indirect mechanisms. For instance, low levels of C/EBPa may
modulate genes essential for self-renewal 19,30, whereas increased levels of C/EBPa in adult
HSCs may regulate additional sets of factors associated with cell cycle. It is possible that a
developmental stage-dependent bone marrow microenvironment triggers the activation of
unique genetic programs in HSC. However, the fact that the pace of HSC temporal
alternation does not seem to be affected by the microenvironment following
transplantation10, rather suggests an intrinsically timed developmental event31,32.
Transcription factor Sox17 has been linked to the transition of fetal to adult HSCs. Sox17 is
required for the maintenance of fetal, neonatal but not adult hematopoiesis11,27. Moreover,
ectopic expression of Sox17 confers fetal HSC characteristics to adult hematopoietic
progenitors27. In C/EBPa KO SLAM+ HSCs, we did not detect the change of Sox17
expression by microarray and qPCR (data not shown), suggesting that C/EBPa might
function downstream of Sox17. This hypothesis is supported by the observation that C/EBPa
is significantly down-regulated, while its downstream target N-Myc is up-regulated,
following the ectopic expression of Sox17 in adult hematopoietic progenitors 27.
Intriguingly, although C/EBPa adult KO HSCs exhibit enhanced repopulation ability than
the wild-type control as well as enriched expression of fetal HSCs associated signature, they
are still unable to fully regain the reconstitution capacity as fetal HSCs, as evidenced by the
lower frequency of reconstituted mice and the lower degree of chimerism (Figure S6a and
S6b). These data suggested that C/EBPa is a key factor, yet not the only one, that is crucial
to FL HSC identity and function. Other factors involving in HSC homing, engraftment and
reconstitution might as well be required.
Myc genes are associated with a variety of aspects of cellular physiology including
proliferation, apoptosis, differentiation, cellular metabolism, and DNA synthesis 33.
Counteraction between C/EBPa and C-Myc has been reported in adipogenesis and
myelopoiesis34,35. However, loss of C/EBPa in HSCs did not significantly change levels of
c-Myc expression, nor reduced levels of C-Myc by shRNA had an impact on proliferation of
KO HSPCs (data not shown). Therefore, it is less likely that elevated protein or enhanced
activity of C-Myc contributes significantly to proliferation of KO HSCs. Indeed, in this
study we show that enhanced proliferation exhibited in KO HSCs is at least partially
mediated by N-Myc. We find that both C/EBPa KO HSCs with characteristics that resemble
fetal HSCs and FL HSCs themselves express high levels of N-Myc, and down-regulating N-
Myc in either of them diminishes HSC proliferation (Figure 6), indicating its crucial role in
maintaining the active state of HSCs. It is likely that N-Myc activates yet to be identified
genes modulating cell cycle machinery. As loss of the mouse N-Myc gene results in
embryonic lethality between E10.5 and E12.5 probably from neuroectodermal and heart
defects36,37, future investigations on HSC behavior and its molecular profiling in mice that
the N-Myc gene is specifically disrupted in fetal hematopoiesis would be required to define
pathways essential for HSC proliferation. It would be also interesting to know whether N-
Myc mediated proliferation also account for the expansion of functional LT-HSCs, which is
seen both in C/EBPa deficient mice and wild type FL during early development.
In conclusion, we provide functional and genome-wide evidences that C/EBPa acts as a
molecular switch for acquisition and maintenance of adult HSC properties and demonstrate
a remarkable capacity of a single transcription factor in determination of HSC identity.
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Figure 1.
Loss of C/EBPa increases the number of phenotypic and functional hematopoietic stem cells
(HSCs)
(a, b) Increased frequency of Lineage-c-kit+Sca-1+ cells (KSLs), but decreased frequency of
HSC-enriched CD150+CD48- (SLAM+) in the KSL fraction in C/EBPa conditional
knockout (KO) mouse bone marrow. Representative FACS plots analyzing bone marrow
cells 5-7 days after last pIpC injections are shown for control (Ctl, a) and KO (b) mice.
Numbers in plots indicate average percentages of boxed populations (±SD) among total
bone marrow cells or gated populations (p<0.005, data pooled from four independent
experiments to obtain n=15 per genotype).
(c-e) Total numbers of bone marrow cells (c), KSLs (d), SLAM+KSLs (e) in the bone
marrow (2 femurs, tibias and humerus) of Ctl and KO mice; mean values (±SD) are shown
(**p<0.01 and ***p<0.005, data pooled from four independent experiments to obtain n=15
per genotype).
(f, g) Loss of C/EBPa increases the number of functional HSCs in adult mice. Limiting-
dilution competitive repopulation analyses using either two doses (6 and 12 cells) of sorted
SLAM+KSLs (f) or three doses (5000, 20000, and 50000 cells) of whole bone marrow cells
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(g). Non-responders are defined as recipients with less than 0.3% donor-derived myeloid
and/or lymphoid cells in nucleated peripheral blood cells. The frequency of functional HSCs
(competitive repopulation units, CRU) was calculated according to Poisson statistics using
L-Calc software (P<0.005). f, plotted is the percentage of non-responders 24 weeks after
transplantation versus the number of initial SLAM+KSLs from two independent
experiments. g, the frequency and the total number of CRU in bone marrow per mouse were
measured and calculated.
See also Figure S1 and table S6 for raw values for figure S1.
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Figure 2.
HSC expansion upon loss of C/EBPa is hematopoietic cell intrinsic
(a-c) Bone marrow chimeras. 2×106 total bone marrow cells from either Mx.1-Cre- C/
EBPaloxP/loxP or Mx.1-Cre+ C/EBPaloxP/loxP mice were transplanted into lethally irradiated
Mx.1-Cre+ C/EBPaloxP/loxP or Mx.1-Cre- C/EBPaloxP/loxP recipients prior to pIpC injections.
After stable engraftment (3 months), pIpC was administered to induce deletion. The
chimeras were analyzed 2 weeks after the last injection. (a) experimental outline; (b) total
number of KSLs in the chimeric mouse bone marrow; mean values (±SD) are shown (n=2
mice for group #1, 3 and 4, and n=3 mice for group #2); and (c) representative FACS
analyses of lineage-negative bone marrow cells.
(d, e) Competitive bone marrow chimeras. Untreated Mx.1-Cre- C/EBPaloxP/loxP and Mx.1-
Cre+ C/EBPaloxP/loxP bone marrow cells were mixed with CD45.1+ wild type congenic
mouse bone marrow at a 1:4 ratio and transplanted into lethally irradiated CD45.1+
recipients. C/EBPa excision was induced 2 months after transplantation by pIpC injection
and mice were analyzed 7 days after the last injection. (d) Experiment outline, and (e)
Percentages of KSL cells in either CD45.1+ Lin- or CD45.2+ Lin- population in bone
marrow chimeras. Values are means (±SD) (n=3 mice for each chimera group, ***p<0.005;
NS stands for no statistical significance).
See also Figure S2 and Table S6 for the raw data for panels 2b and 2e.
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Figure 3.
Loss of C/EBPa increases HSC proliferation
(a) Pyronin Y/Hoechst staining showing cell cycle status of SLAM+KSLs in control and KO
mice 5 days after pIpC injections.
(b) Distribution of SLAM+KSLs in G0, G1 and S/G2-M phases. Mean values (±SD) are
shown (n=3 independent mice for each group, ***p<0.005 and *p<0.05).
(c) Representative FACS plots demonstrating BrdU incorporation in donor derived
SLAM+KSLs 20 hours after BrdU injection in reconstituted chimera mouse bone marrow
four months after pIpC administration (***p<0.005).
(d) Percentage of BrdU+ cells in donor-derived SLAM+KSLs sorted from control and KO
chimeras (***p<0.005).
(e, f) GSEA comparison of KO and control SLAM+KSLs for enrichment/depletion of HSC
proliferation-associated gene expression (e) and quiescence associated gene expression (f).
The normalized enrichment scores (NES) and p values are indicated in each plot.
(g) qPCR analysis of the expression of selected cell cycle related genes that were
differentially expressed by KO versus control SLAM+ KSLs revealed by microarray
analysis. The results shown are the relative expression levels and expressed as fold
difference compared to the levels (set to 1) detected in control SLAM+ KSLs. The data are
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the averages ± SD for n=3 independently sorted SLAM+ KSLs per group two weeks after
pIpC injections. The average for each sample was calculated from duplicate measurements.
(***p<0.005, gapdh normalization).
See also Figure S3 and table S6 for the raw data for panels 3b, 3g, S3b and S3d.
Ye et al. Page 15
Nat Cell Biol. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4.
Loss of C/EBPa in adult HSCs results in transcriptional alterations that resemble fetal liver
(FL) HSCs
(a) Unsupervised clustering of control, KO bone marrow HSCs (7 days and 21 days after
pIpC injection) and E15.5 FL HSCs using differentially expressed genes (DEG) between
control and KO.
(b) The heat map represents gene signature shared by KO adult HSCs and E15.5 FL HSCs,
but distinct from that of control adult HSCs (1.5 change-filtered, P < 0.05).
(c) GSEA comparison of KO and control adult HSCs for enrichment/depletion of FL HSC
associated gene expression. The normalized enrichment scores (NES) and p values are
indicated on each plot.
See also Table S1.
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Figure 5.
Up-regulation of C/EBPa limits HSC proliferation
(a) qPCR analysis showing levels of C/EBPa in SLAM+KSLs from E15.5 fetal liver
(Mac-1low SLAM+KSLs), bone marrow of 2-week old mice (Mac-1low SLAM+KSLs) and
4-, 8- and 20-week old mice (Mac-1- SLAM+KSL), respectively. Mean value of duplicate
measurements of C/EBPa levels relative to gapdh from one representative experiment are
shown in the plot. Data show result of one of three independent experiments.
(b, c) Percentage of BrdU+ cells in SLAM+ KSLs from 1.5-week old (b) or 4.5-week old
control and KO mice (c) 14 hours after Brdu incorporation (***p<0.005). Data are obtained
from two independent experiments.
(d) Over-expression of C/EBPa decreased fetal liver KSL proliferation. Percentage of
GFP+c-kit+ FL KSLs in G0, G1 and S/G2-M phase 48 hours following infection with
MSCV-GFP-C/EBPa (MIG-C/EBPa) or MIG control virus, measured by Pyronin/Hoechest
staining. Mean value (±SD) are shown (n=3 of independent FL KSL samples for each group,
data collected over two experiments: one sample coming from one experiment and 2 from
the other experiment, ***p<0.005, *p<0.05).
See also Figure S4 and table S6 for the raw data for panels 5a and 5d.
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Figure 6.
N-Myc is a downstream target of C/EBPa that mediates its regulation of HSC proliferation
during fetal to adult transition
(a) Pathway analysis indicating enriched gene sets and pathways downstream of C/EBPa.
Percentages in the y axis represent either the percentage of the number of genes in the
pathway of interest relative to the total number of genes (Genomic background, blue bars),
or the number of differentially expressed genes in the pathway of interest to all differentially
expressed genes (Differential expression, red bars).
(b) Up-regulation of N-Myc expression in KO SLAM+KSLs measured by qPCR. Results are
shown as mean (±SD) of triplicate measurements of relative mRNA in one representative
experiment (normalized to gapdh). Data show results of one of three independent
experiments.
(c) Re-introduction of C/EBPa into C/EBPa KO KSLs reduces N-Myc expression. Results
from one representative experiment are shown. Left, mean value of duplicate measurements
of C/EBPa; right, mean value of the relative N-Myc expression in MIG-C/EBPa infected
KO KSLs, with the levels in MIG-infected cells set to 1. Data show results of one of two
independent experiments.
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(d) ChIP-qPCR analysis confirms specific binding of CEBPa to the N-Myc promoter in
hematopoietic stem/progenitor cells (Lineage- c-kit+). Results are shown as mean value of
duplicate measurements. Data show results of one of two independent experiments.
(e) Upper, schematic diagram showing three potential C/EBPa binding sites within the N-
Myc proximal promoter. Red bars represent consensus C/EBPa binding sites and black bar
represents N-Myc gene. lower, reporter assays comparing transcriptional activity of reporter
constructs with full length or truncated N-Myc promoters upon the addition of C/EBPa in
HEK293 cells. Mean value (±SD) of triplicate measurements of one of two independent
experiments are shown.
(f) shRNA-mediated knocking-down of N-Myc in adult C/EBPa-deficient KSLs decreased
their proliferation as measured by Pyronin/Hoechst staining. Results are shown as mean
value (±SD) (n=7 independent samples for each group, pooled over three experiments).
(g) qPCR of N-Myc in SLAM+KSLs. Results are shown as mean (±SD) of triplicate
measurements of N-Myc transcripts in one of two independent experiments.
(h) shRNA-mediated knocking down of N-Myc in FL KSLs decreased their proliferation.
Results are shown as mean value (±SD) (n=4 independent samples per group, data pooled
over two experiments, ***p<0.005 and *p<0.05).
See also Figure S5 and table S6 for the raw data for panels 6b, 6c, 6d, 6e, 6g, 6h and S5a.
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Figure 7.
C/EBPa plays a key role in regulating acquisition and maintenance of adult HSC quiescence
Model summarizing the modulation of HSC proliferation properties by C/EBPa during fetal/
adult transition. Top panel: Fetal and newborn HSCs express low levels of C/EBPa and high
levels of N-Myc, which sustain the active proliferation of fetal HSCs. During the fetal to
adult transtition, C/EBPa expression increases in HSCs, which subsequently inhibits N-Myc
activity through direct transcriptional repression. As a consequence, HSCs become
quiescent. Bottom panel: Inactivation of C/EBPa by conditional ablation of C/EBPa releases
its inhibition of N-Myc expression. Elevated N-Myc expression in adult HSCs re-activates
their proliferation that resembles the fetal HSC.
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